• +41 91 682 20 40
  • info@elixi-int.com
  • Reserved Area
    • Login
    • Register
    • Request Document
    • Send Document
logo
  • Home
  • About Us
  • Services
  • Quality
  • News
  • Case Studies
  • Contact

Let's talk

info@yourwebsite.com
+1 (555) 123-4567

  • Search

Senza categoria

19 November 2019

Ervebo, First vaccine to protect against Ebola


by Elixi

12 November 2019

Baqsimi (glucagon), first non-injectable treatment for severe low blood sugar levels


by Elixi

5 November 2019

Reyvow (lasmiditan), new treatment for patients with migraine


by Elixi

4 November 2019

Trikafta (elexacaftor/ivacaftor/tezacaftor), new breakthrough therapy for cystic fibrosis


by Elixi

1 October 2019

Mavyret (glecaprevir and pibrentasvir), a treatment for adults and children with all genotypes of hepatitis C and compensated cirrhosis, shortens the duration of treatment to eight weeks


by Elixi

24 September 2019

Rybelsus (semaglutide), first oral GLP-1 treatment for type 2 diabetes


by Elixi

23 September 2019

Ofev (nintedanib), first treatment for patients with rare type of lung disease


by Elixi

7 September 2019

Nourianz (istradefylline), new add-on drug to treat off episodes in adults with Parkinson’s disease


by Elixi

31 August 2019

Xenleta (lefamulin), new antibiotic to treat community-acquired bacterial pneumonia


by Elixi

22 August 2019

Inrebic (fedratinib) capsules, new treatment for adult patients with certain types of myelofibrosis


by Elixi

  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13